Hamps Bio Limited is set to launch its IPO. The IPO will open on 13 December 2024 (Friday) and close on 17 December 2024 (Tuesday). This is a Fixed Price issue. Through this issue, the company aims to raise approximately ₹6.22 crores from potential investors.
The IPO consists of a fresh issue of 1220000 equity shares amounting to ₹6.22 crore. There is no Offer for Sale in this issue. The face value of the shares is ₹2 per share, and the issue price is set at ₹51 per share. Investors can bid for a minimum lot size of 2000 shares.
IPO Key Highlights
| Category | Detail | Information |
|---|---|---|
| Key Dates | IPO Open Date | December 13, 2024 |
| IPO Close Date | December 17, 2024 | |
| Listing Date | December 20, 2024 | |
| Pricing Information | Face Value | ₹10 per share |
| Price | ₹51 per share | |
| Offer Structure | Total Issue Size | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Fresh Issue | 1,220,000 shares (aggregating up to ₹6.22 Cr) | |
| Investor Details | Lot Size | 2,000 Shares |
| Listing Exchange | BSE SME | |
| IPO Type | Fixed Price Issue IPO |
Important Dates to Remember
| Event | Date |
|---|---|
| IPO Opening Date | 13 December, 2024 (Friday) |
| IPO Closing Date | 17 December, 2024 (Tuesday) |
| Basis of Allotment | 18 December, 2024 (Wednesday) |
| Initiation of Refunds | 19 December, 2024 (Thursday) |
| Credit of Shares to Demat Account | 19 December, 2024 (Thursday) |
| Listing Date | 20 December, 2024 (Friday) |
What is GMP of Hamps Bio Ltd IPO Today?
As of December 18, 2024, the Grey Market Premium (GMP) for the Hamps Bio Ltd IPO is ₹55. This indicates that the shares are expected to list at approximately ₹106 per share.
Note: GMP is an unofficial indicator and is based on market speculation; it does not guarantee actual listing performance.
Company Financial Standing
| Period | 31 Oct 2024 (₹ Lakhs) | 31 Mar 2024 (₹ Lakhs) | 31 Mar 2023 (₹ Lakhs) | 31 Mar 2022 (₹ Lakhs) |
|---|---|---|---|---|
| Total Assets | 644.00 | 514.77 | 395.87 | 364.31 |
| Total Revenue | 436.42 | 650.13 | 558.49 | 534.46 |
| Total Expense | 390.23 | 585.13 | 522.78 | 523.98 |
| Profit After Tax | 34.08 | 50.07 | 35.90 | 12.15 |
| Company’s Net Worth | 370.78 | 337.42 | 136.30 | 100.57 |
| Total Reserves & Surplus | 57.18 | 141.42 | -13.70 | -49.43 |
Company’s Key Performance Indicators
| Key Performance Indicator | Value |
|---|---|
| Return on Capital Employed (ROCE) | 18.31% |
| Return on Equity (ROE) | 21.14% |
| Debt to Equity Ratio | 0.31 |
| Return on Net Worth (RoNW) | 14.84% |
| EBITDA Margin (%) | 18.18% |
| After Tax Profit Margin (%) | 7.73% |
| Net Asset Value (NAV) | ₹17.22 |
| Earnings Per Share (EPS) | ₹1.76 |
| Price to Book Value (P/BV) | 2.96 |
Lot Size and Application Amount
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail Investor (Minimum Lot) | 1 | 2000 | ₹102,000 |
| Retail Investor (Maximum Lot) | 1 | 2000 | ₹102,000 |
| HNI Investor (Minimum Lot) | 2 | 4000 | ₹204,000 |
Investor Category-Wise Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | 5.08% of the total issue |
| Retail Shares Offered | 50% of the total issue |
| NII (HNI) Shares Offered | 44.92% of the total issue |
Net Cash Flow Generated
| Activity | For the period ended October 31, 2024 (₹ Lakhs) | March 31, 2024 (₹ Lakhs) | March 31, 2023 (₹ Lakhs) | March 31, 2022 (₹ Lakhs) |
|---|---|---|---|---|
| Net Cash from Operating Activity | 74.53 | -29.15 | 122.95 | 33.27 |
| Net Cash Used in Investing Activities | -95.85 | -36.69 | -74.92 | 50.82 |
| Net Cash from Financing Activities | 26.04 | 66.79 | -48.27 | -94.41 |
| Net (Decrease)/Increase in Cash | 4.72 | 1.95 | -0.24 | -10.32 |
Segment-wise Revenue Distribution
| Service | For the period ended October 31, 2024 (₹ Lakhs) | Fiscal 2024 (₹ Lakhs) | Fiscal 2023 (₹ Lakhs) | Fiscal 2022 (₹ Lakhs) |
|---|---|---|---|---|
| Pharma | 211.64 | 366.43 | 377.77 | 393.15 |
| FDFP | 215.03 | 281.10 | 180.05 | 140.89 |
| Total | 426.67 | 647.53 | 557.81 | 534.05 |
State Wise Revenue Generation
| State | 30 June 2024 (₹ Lakhs) | FY 2024 (₹ Lakhs) | FY 2023 (₹ Lakhs) | FY 2022 (₹ Lakhs) |
|---|---|---|---|---|
| Gujarat | 188.11 | 329.47 | 330.10 | 339.38 |
| Maharashtra | 8.38 | 5.73 | 13.63 | 12.94 |
| Dadra and Nagar Haveli | 4.13 | 8.27 | 6.35 | 13.23 |
| Rajasthan | 5.67 | 12.23 | 12.20 | 17.13 |
| Bihar | 3.04 | 6.61 | 10.87 | 1.07 |
| Madhya Pradesh | 0.88 | 3.16 | 2.36 | 4.98 |
| Others | 1.43 | 9.23 | 2.25 | 4.42 |
Key Objectives of this Issue
The net proceeds from the issue will be utilized for the following purposes.
- To Purchase the new machinery for the FMCG division
- To enhancing the visibility and awareness of its brand.
- General corporate purposes.
Positives & Negatives of Hamps Bio Ltd
Positives:
- Experienced Leadership Team
- Wide Range of Products and Services
- Focus on Innovation and Quality
- Strong Market Presence
Negatives:
- Dependence on some selected markets.
- Tough Competition in the Industry.
- Exposure to Regulatory Changes.
- Lack of Diversification.
Popular Questions
- What are the opening and closing dates for the Hamps Bio Ltd IPO?
The issue opens on 13 December, 2024, and closes on 17 December, 2024. - What is the issue price for the Hamps Bio Ltd IPO?
The issue price is ₹51 per equity share . - What is the lot size for retail investors in this offer?
Retail investors can bid for a minimum of 2,000 shares, amounting to ₹1,02,000 (at the issue price) . - Who is the lead manager for this issue?
The lead manager is Marwadi Chandarana Intermediaries Brokers Private Limited . - Who is the registrar for the Hamps Bio Ltd IPO? The registrar is Bigshare Services Pvt Ltd .
- What are the main objectives of this issue?
the fund raised through this issue will be utilized for working capital requirements, business expansion, and general corporate purposes . - On which stock exchange will the shares be listed?
The shares of Hamps Bio ltd are proposed to be listed on the BSE SME platform . - What is the total issue size for the Hamps IPO?
The total isses 12,20,000 equity shares . - When will the allotment and refund process begin?
The allotment date ier 18, 2024**, and refunds will begin on December 19, 2024 . - When will the shares be credited to the Demat account?
Shares will be credited in the Demat accounts on December 19, 2024 . - What is the expected listing date for the offer?
The shares are expected to list on 20 December, 2024 .
It is always beneficial to read Draft Red Herring Prospectus (DRHP) and Red Herring Prospectus (RHP) carefully to better understand its financials and growth opportunities before making a decision.
Looking for more IPO reviews? Check out our IPO Dashboard for recent posts on other Main-board IPO & SME IPOs for the latest market updates.
Note: This article is based on the information received from the company’s official documents, including the Draft Red Herring Prospectus (DRHP) and Red Herring Prospectus (RHP). For up-to-date information on the Grey Market Premium (GMP) for the Hamps Bio Ltd IPO, you may please check our Current GMP, where we will post the latest figures as soon as they are available.
Disclaimer: This article is for educational purposes only. We do not offer any advice on buying or selling securities. Please consult your financial advisor before investing in an IPO or any other securities to make sure that it suits your financial plans and risk tolerance.
Don’t miss out on the latest IPOs – Click here to Find Upcoming IPOs.
“Invest Smarter, Faster – Click Here to Open Your Free Demat Account Today!”
“If this article was useful to you, feel free to share it with others who might find it helpful. Your feedback is important, so drop your questions or thoughts in the comments—we’d love to hear from you!”
Looking for the latest updates on upcoming IPOs? Explore detailed insights, expert reviews, and key information on these trending IPOs:
Dhanlaxmi Crop Science IPO 2024 Price, GMP & Allotment- A Comprehensive Report
Toss The Coin Limited IPO 2024 Price, GMP & Allotment- A Complete Report
Leave a comment